New research provides more evidence that dried blood samples collected from a simple finger prick can be used to measure key biomarkers of Alzheimer’s disease (AD). In a multicenter study of more than ...
Blood testing company Theranos was once valued at $10 billion, but false claims over its testing abilities led to one of the greatest collapses in the history of the health care industry — and landed ...
The DROP-AD project, conducted across seven European medical centers including the University of Gothenburg and University of Exeter, successfully tested 337 participants and proved that finger-prick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results